Yang T, Chakraborty S, Mandal J, Mei X, Joe B. Microbiota and metabolites as factors influencing blood pressure regulation. Compr Physiol. 2021;11(2):1731–57. https://doi.org/10.1002/cphy.c200009.
Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–36. https://doi.org/10.1042/BCJ20160510.
Article CAS PubMed Google Scholar
Smiljanec K, Lennon SL. Sodium, hypertension, and the gut: does the gut microbiota go salty? Am J Physiol-Heart Circ Physiol. 2019;317(6):H1173–82.
Article CAS PubMed PubMed Central Google Scholar
Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut microbiota in hypertension and atherosclerosis: a review. Nutrients. 2020;12(10). https://doi.org/10.3390/nu12102982.
Jovel J, Nimaga A, Jordan T, O’Keefe S, Patterson J, Thiesen A, et al. Metagenomics versus metatranscriptomics of the murine gut microbiome for assessing microbial metabolism during inflammation. Front Microbiol. 2022;13:829378. https://doi.org/10.3389/fmicb.2022.829378.
Article PubMed PubMed Central Google Scholar
Hou K, Wu Z-X, Chen X-Y, Wang J-Q, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. https://doi.org/10.1038/s41392-022-00974-4.
Article PubMed PubMed Central Google Scholar
Teichmann J, Cockburn DW. Fermentation reveals changes in butyrate production dependent on resistant starch source and microbiome composition. Front Microbiol. 2021;12:640253. https://doi.org/10.3389/fmicb.2021.640253.
Article PubMed PubMed Central Google Scholar
Cheng H-Y, Ning M-X, Chen D-K, Ma W-T. Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol. 2019;10:607.
Article CAS PubMed PubMed Central Google Scholar
Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65(6):1331–40.
Article CAS PubMed Google Scholar
Ferguson JF, Aden LA, Barbaro NR, Van Beusecum JP, Xiao L, Simmons AJ, et al. High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension. JCI Insight. 2019;5(13). https://doi.org/10.1172/jci.insight.126241.
Elijovich F, Laffer CL, Sahinoz M, Pitzer A, Ferguson JF, Kirabo A. The gut microbiome, inflammation, and salt-sensitive hypertension. Curr Hypertens Rep. 2020;22(10):79. https://doi.org/10.1007/s11906-020-01091-9.
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Zhu Y, Wu C, Lu A, Deng M, Yu H, et al. Gut dysbiosis contributes to high fructose–induced salt-sensitive hypertension in Sprague-Dawley rats. Nutrition. 2020;75: 110766.
Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, et al. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens. 2022;36(11):952–9. https://doi.org/10.1038/s41371-022-00698-6.
Article PubMed PubMed Central Google Scholar
Martin AM, Sun EW, Rogers GB, Keating DJ. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front Physiol. 2019;10:428. https://doi.org/10.3389/fphys.2019.00428.
Article PubMed PubMed Central Google Scholar
Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. https://doi.org/10.1186/s40168-016-0222-x.
Article PubMed PubMed Central Google Scholar
Tuteja S, Ferguson JF. Gut microbiome and response to cardiovascular drugs. Circ Genom Precis Med. 2019;12(9):421–9. https://doi.org/10.1161/CIRCGEN.119.002314.
Article CAS PubMed PubMed Central Google Scholar
Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14(5):273–87. https://doi.org/10.1038/nrmicro.2016.17.
Article CAS PubMed PubMed Central Google Scholar
Wu Y, Xu H, Tu X, Gao Z. The role of short-chain fatty acids of gut microbiota origin in hypertension. Front Microbiol. 2021;12:730809. https://doi.org/10.3389/fmicb.2021.730809.
Article PubMed PubMed Central Google Scholar
Bartolomaeus H, Balogh A, Yakoub M, Homann S, Markó L, Höges S, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407–21. https://doi.org/10.1161/CIRCULATIONAHA.118.036652.
Article CAS PubMed Google Scholar
Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964–77. https://doi.org/10.1161/CIRCULATIONAHA.116.024545.
Article CAS PubMed Google Scholar
Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132(6):701–18. https://doi.org/10.1042/CS20180087.
Article CAS PubMed Google Scholar
• Shi H, Zhang B, Abo-Hamzy T, Nelson JW, Ambati CSR, Petrosino JF, et al. Restructuring the gut microbiota by intermittent fasting lowers blood pressure. Circ Res. 2021;128(9):1240–54. https://doi.org/10.1161/CIRCRESAHA.120.318155. This is an important study demonstrating that intermittent fasting lowers blood pressure by altering the gut microbiota composition and metabolome in spontaneously hypertensive stroke-prone rat.
Chakraborty S, Galla S, Cheng X, Yeo JY, Mell B, Singh V, et al. Salt-responsive metabolite, β-hydroxybutyrate, attenuates hypertension. Cell Rep. 2018;25(3):677–89.e4. https://doi.org/10.1016/j.celrep.2018.09.058.
Article CAS PubMed PubMed Central Google Scholar
Ishimwe JA, Baker MB, Garrett MR, Sasser JM. Periconceptional 1,3-butanediol supplementation suppresses the superimposed preeclampsia-like phenotype in the Dahl salt-sensitive rat. Am J Physiol Heart Circ Physiol. 2022;322(2):H285–95. https://doi.org/10.1152/ajpheart.00060.2021.
Article CAS PubMed Google Scholar
Ishimwe JA, Garrett MR, Sasser JM. 1,3-Butanediol attenuates hypertension and suppresses kidney injury in female rats. Am J Physiol Renal Physiol. 2020;319(1):F106–14. https://doi.org/10.1152/ajprenal.00141.2020.
Article CAS PubMed PubMed Central Google Scholar
Konopelski P, Ufnal M. Indoles-gut bacteria metabolites of tryptophan with pharmacotherapeutic potential. Curr Drug Metab. 2018;19(10):883–90.
Article CAS PubMed Google Scholar
• Paeslack N, Mimmler M, Becker S, Gao Z, Khuu MP, Mann A, et al. Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease. Amino Acids. 2022;54(10):1339–56. https://doi.org/10.1007/s00726-022-03161-5. This review covers the current research directions by providing clinical evidence for the involvement of microbiota-derived trytophan metabolities in blood pressure regulation and CVD's.
Bartosiewicz J, Kaminski T, Pawlak K, Karbowska M, Tankiewicz-Kwedlo A, Pawlak D. The activation of the kynurenine pathway in a rat model with renovascular hypertension. Exp Biol Med. 2017;242(7):750–61. https://doi.org/10.1177/1535370217693114.
Wang Y, Liu H, McKenzie G, Witting PK, Stasch J-P, Hahn M, et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med. 2010;16(3):279–85. https://doi.org/10.1038/nm.2092.
Article CAS PubMed PubMed Central Google Scholar
Lu W, Wang Y, Fang Z, Wang H, Zhu J, Zhai Q, et al. Bifidobacterium longum CCFM752 prevented hypertension and aortic lesion, improved antioxidative ability, and regulated the gut microbiome in spontaneously hypertensive rats. Food Funct. 2022;13(11):6373–86. https://doi.org/10.1039/D1FO04446J.
Article CAS PubMed Google Scholar
Robles-Vera I, de la Visitación N, Toral M, Sánchez M, Romero M, Gómez-Guzmán M, et al. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension. FASEB J. 2020;34(10):13626–40. https://doi.org/10.1096/fj.202001532R.
Article CAS PubMed Google Scholar
Liu J, Zhang D, Guo Y, Cai H, Liu K, He Y, et al. The effect of Lactobacillus consumption on human blood pressure: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;54:102547. https://doi.org/10.1016/j.ctim.2020.102547.
Robles-Vera I, Toral M, de la Visitación N, Sánchez M, Gómez-Guzmán M, Romero M, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids. Mol Nutr Food Res. 2020;64(6):e1900616. https://doi.org/10.1002/mnfr.201900616.
Article CAS PubMed Google Scholar
• Valeri F, Endres K. How biological sex of the host shapes its gut microbiota. Front Neuroendocrinol. 2021;61:100912. doi:https://doi.org/10.1016/j.yfrne.2021.100912. This review provides a comprehensive description of current knowledge on sex-dependent diffrences in gutr microbiota composition in both human, and animal stidues, and discuss the active role of sex hormones in structuring the gut microbiota.
Muiesan ML, Salvetti M, Rosei CA, Paini A. Gender differences in antihypertensive treatment: myths or legends? High Blood Press Cardiovasc Prev. 2016;23(2):105–13. https://doi.org/10.1007/s40292-016-0148-1.
Article CAS PubMed Google Scholar
Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P. Prevalence of apparent treatment-resistant hypertension in the United States. Hypertension. 2019;73(2):424–31. https://doi.org/10.1161/HYPERTENSIONAHA.118.12191.
Article CAS PubMed Google Scholar
Lamirault G, Artifoni M, Daniel M, Barber-Chamoux N, Nantes University Hospital Working Group On H. Resistant hypertension: Novel insights. Curr Hypertens Rev. 2020;16(1):61–72. https://doi.org/10.2174/1573402115666191011111402.
Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53–90. https://doi.org/10.1161/HYP.0000000000000084.
留言 (0)